15110 DALLAS PKWY, SUITE 600, DALLAS, TX
Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Secures $2.5 Million Strategic Investment in IP Holdings; Receives Initial $1.75 Million Tranche
Termination of Business Combination Agreement with Nuclea Energy Inc.
Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Ex-99.1
Mangoceuticals, Inc. Enters Subscription Agreement for $272,000
Reg. FD
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Amended Quarterly Report
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities
Definitive Proxy Statement
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload